Trial Profile
Phase II Study of SCH 530348 in Subjects With Acute Coronary Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Vorapaxar (Primary) ; Aspirin; Ticlopidine
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Sponsors Schering-Plough
- 13 Jun 2008 New trial record.